H40.43 Glaucoma secondary to eye inflammation, bilateral

Name of the Condition

• Glaucoma Secondary to Eye Inflammation, Bilateral

Summary

Glaucoma secondary to eye inflammation, bilateral, is a condition where increased intraocular pressure (IOP) or optic nerve damage occurs as a result of inflammatory processes affecting both eyes. This form of glaucoma may develop due to acute or chronic inflammation disrupting the eye’s drainage structures or optic nerve, potentially leading to vision loss if not managed. The term "bilateral" specifies that both eyes are affected.

Causes

The condition arises from inflammation that disrupts the eye’s normal fluid drainage or damages the optic nerve. Common mechanisms include uveitis, scleritis, or other inflammatory disorders that affect the trabecular meshwork, angle structures, or optic nerve head. Inflammation may be acute (sudden onset) or chronic (long-standing), and the underlying cause of the inflammation (e.g., autoimmune, infectious) is not specified in this code.

Risk Factors

• Chronic or recurrent eye inflammation (e.g., uveitis).
• Autoimmune conditions (e.g., rheumatoid arthritis, sarcoidosis).
• Infections affecting the eye (e.g., viral or bacterial).
• Prior eye surgery or trauma that triggers inflammation.
• Use of topical or systemic medications that induce ocular inflammation.

Symptoms

• Elevated intraocular pressure (detected via tonometry).
• Vision changes, such as blurred vision or halos around lights.
• Eye pain, redness, or discomfort.
• Progressive vision loss, particularly in peripheral fields.

Diagnosis

Diagnosis requires a thorough eye examination, including tonometry to measure IOP, gonioscopy to assess the drainage angle, and imaging (e.g., optical coherence tomography) to evaluate optic nerve damage. Bilateral involvement is confirmed by examining both eyes.

Treatment Options

Treatment focuses on reducing inflammation and lowering IOP. Options may include anti-inflammatory medications (e.g., corticosteroids), IOP-lowering drugs (e.g., prostaglandin analogs), or surgical interventions (e.g., trabeculectomy) if needed. Management of underlying inflammatory conditions is also critical.

Prognosis and Follow-Up

Prognosis depends on early detection and effective management of inflammation and IOP. Regular follow-up with an eye care provider is essential to monitor IOP, optic nerve health, and vision. Untreated or poorly controlled inflammation can lead to permanent vision loss.

Complications

• Permanent vision loss or blindness.
• Optic nerve damage.
• Corneal scarring or clouding.
• Cataract formation.

Lifestyle & Prevention

• Manage underlying inflammatory conditions (e.g., autoimmune diseases) with appropriate treatment.
• Avoid eye trauma or injury.
• Follow prescribed medication regimens to control inflammation.
• Protect eyes from infections (e.g., proper hygiene, avoiding contaminated substances).

When to Seek Professional Help

Seek immediate medical attention if you experience sudden vision changes, severe eye pain, redness, or halos around lights. Regular eye exams are recommended for individuals with risk factors to detect early signs of glaucoma.

Tips for Medical Coders

Use this code for bilateral glaucoma secondary to eye inflammation when documentation specifies involvement of both eyes. Ensure the underlying inflammatory cause is not coded separately unless explicitly documented. Verify that the condition is not better described by another code (e.g., primary glaucoma) and that bilateral involvement is clearly stated.